ArticleCancer research2024

Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib.

Peihong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.